Description
What Is Delta-8-THC and How Is It Different from Delta-9 THC?
THC or delta-9-tetrahydrocannabinol is by far the most well-known cannabinoid, but certainly isn’t the only powerful chemical compound native to the cannabis flower. Delta-8-THC, one of the four most common cannabinoids, is similar to its psychoactive relative THC, but with several key differences.
What Is Delta-8-THC?
According to the National Cancer Institute, delta-8-THC can be defined as:
“An analogue of tetrahydrocannabinol (THC) with antiemetic, anxiolytic, appetite-stimulating, analgesic, and neuroprotective properties. [Delta-8-THC] binds to the cannabinoid G-protein coupled receptor CB1, located in the central nervous system…This agent exhibits a lower psychotropic potency than [delta-9-THC], the primary form of THC found in cannabis.”
It wasn’t until 1995 when an Israeli study conducted by Shaare Zedek Hospital, Bikur Holim Hospital, and the Hebrew University administered delta-8 THC to children with cancer. The study’s lead author was no other than Dr. Raphael Mechoulam, who is also known as the father of THC. The study’s authors wrote that by the time the research was published, there were already 480 cases of successful treatments using delta-8 to treat cancer. Aside from helping the children, delta-8 also helped treat the vomiting.
Today, we know that delta-8 activates the same receptors as the main THC cannabinoid, which is the CB1 receptor. It is also beneficial in helping regulate many body functions including sleep, mood, pain, memory, and more. Studies show that delta-8 also acts on the CB2 receptor, which is critical in helping keep the immune system healthy. We also now know that traditional THC is no longer the only compound that gets you high; while delta-8 can do that, its effects are considered more gradual compared to the instant high of THC, which is better for users who tend to get paranoid or anxious.
Many people take 15-90 drops.
Bottle Size: 1 fl oz or 30 ml
Serving Size: 1 ml / 30 drops
Reviews
There are no reviews yet.